Infliximab in moderate to severe ulcerative colitis: comparison between scheduled treatment strategy and bridge strategy

被引：0
|
作者：
Sambuelli, A. [1 ]
Bellicoso, M. [1 ]
Negreira, S. [1 ]
Goncalves, S. [1 ]
Huernos, S. [1 ]
Chavero, P. [1 ]
Tirado, P. [1 ]
Cabanne, A. [2 ]
Gil, A. [1 ]
机构：
[1] Hosp Bonorino Udaondo, IBD Sect, Med, Buenos Aires, DF, Argentina
[2] Hosp Bonorino Udaondo, Dept Pathol, Buenos Aires, DF, Argentina
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P585
引用
收藏
页码：S378 / S379
页数：2
相关论文
共 50 条
  • [1] INFLIXIMAB (IFX) IN MODERATE TO SEVERE ULCERATIVE COLITIS (UC): COMPARISON BETWEEN SCHEDULED TREATMENT STRATEGY AND BRIDGE STRATEGY
    Sambuelli, Alicia M.
    Bellicoso, Maricel I.
    Goncalves, Silvina A.
    Negreira, Silvia
    Huernos, Sergio P.
    Chavero, Paula
    Carraro, Cecilia
    Tirado, Pablo
    Cabanne, Ana
    Gil, Anibal H.
    GASTROENTEROLOGY, 2017, 152 (05) : S402 - S402
  • [2] Cost-Effectiveness of Infliximab Scheduled Maintenance Treatment for the Management of Patients With Moderate-to-Severe Ulcerative Colitis
    Monfared, Amir A. Tahami
    Feagan, Brian G.
    GASTROENTEROLOGY, 2013, 144 (05) : S637 - S637
  • [3] A model of the long-term cost effectiveness of scheduled maintenance treatment with infliximab for moderate-to-severe ulcerative colitis
    Tsai, H. H.
    Punekar, Y. S.
    Morris, J.
    Fortun, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (10) : 1230 - 1239
  • [4] Infliximab in the treatment of severe ulcerative colitis
    Jiménez, JM
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2004, 96 (02) : 89 - 93
  • [5] Infliximab Therapy for Children with Moderate to Severe Ulcerative Colitis: A Step-Up versus a Top-Down Strategy
    Kim, Mi Jin
    Kim, Eunsil
    Kang, Ben
    Choe, Yon Ho
    YONSEI MEDICAL JOURNAL, 2021, 62 (07) : 608 - 614
  • [6] Comparison of Heparin and Steroids in the Treatment of moderate and severe ulcerative colitis
    Panés, J
    Esteve, M
    Cabré, E
    Hinojosa, J
    Andreu, M
    Sans, M
    Fernandez-Bañares, F
    Feu, F
    Gassull, MA
    Piqué, JM
    GASTROENTEROLOGY, 2000, 119 (04) : 903 - 908
  • [7] Infliximab in the treatment of severe refractory ulcerative colitis
    Kohn, A
    Prantera, C
    Pera, A
    Cosintino, R
    Sostegni, R
    Daperno, M
    GASTROENTEROLOGY, 2002, 122 (04) : A615 - A616
  • [8] Infliximab, Azathioprine, or Infliximab plus Azathioprine for Treatment of Moderate to Severe Ulcerative Colitis: The UC Success Trial
    Panccione, Remo
    Ghosh, Subrata
    Middleton, Stephen
    Marquez, Juan R.
    Khalif, Igor
    Flint, Laurence
    van Hoogstraten, Hubert
    Zheng, Hanzhe
    Danese, Silvio
    Rutgeerts, Paul J.
    GASTROENTEROLOGY, 2011, 140 (05) : S134 - S134
  • [9] Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis.
    Panes, J
    Esteve, M
    Cabre, E
    Sans, M
    Hinojosa, J
    Andreu, MG
    Fernandez-Banares, F
    Feu, F
    Gassull, MA
    Pique, JM
    GASTROENTEROLOGY, 2000, 118 (04) : A874 - A874
  • [10] Comparison of the therapeutic efficacy and safety between tacrolimus and infliximab for moderate-to-severe ulcerative colitis: a single center experience
    Nuki, Yoichiro
    Esaki, Motohiro
    Asano, Kouichi
    Maehata, Yuji
    Umeno, Junji
    Moriyama, Tomohiko
    Nakamura, Shotaro
    Matsumoto, Takayuki
    Kitazono, Takanari
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (06) : 700 - 705
12345